Oral versus intramuscular cobalamin treatment in megaloblastic anemia: A single-center, prospective, randomized, open-label study
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (12), 3124-3134
- https://doi.org/10.1016/s0149-2918(03)90096-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Treatment of Vitamin B12–Deficiency Anemia: Oral versus Parenteral TherapyAnnals of Pharmacotherapy, 2002
- Statistics notes: How to randomiseBMJ, 1999
- Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementationThe Lancet, 1999
- VITAMIN B12 DEFICIENCY IN THE ELDERLYAnnual Review of Nutrition, 1999
- VITAMIN B12 ABSORPTION TEST AND ORAL TREATMENT IN 14 CHILDREN WITH SELECTIVE VITAMIN B12 MALABSORPTIONPediatric Hematology and Oncology, 1999
- Oral or parenteral therapy for B12 deficiencyThe Lancet, 1998
- Pernicious AnemiaNew England Journal of Medicine, 1997
- Screening the Older Population for Cobalamin (Vitamin B12) DeficiencyJournal of the American Geriatrics Society, 1995
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975
- ORAL TREATMENT OF PERNICIOUS ANEMIA WITH HIGH DOSES OF VITAMIN B12 WITHOUT INTRINSIC FACTORActa Medica Scandinavica, 1968